There was an interview with Paul from a number of years ago. During the interview he said something along the lines of.... A really well run Biotech company can get an ordinary drug to market, and a poorly run Biotech will struggle to get a blockbuster drug to market....Which one is Imugene?
Also, he said that the game plan is to see a drug at Phase 2.
There was an interview with Paul from a number of years ago....
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.001(1.41%) |
Mkt cap ! $541.6M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.6¢ | 7.1¢ | $738.9K | 10.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 3023978 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 851678 | 8 |
View Market Depth
| Last trade - 10.59am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.4¢ |
Change
0.001 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.6¢ | 7.1¢ | 4766456 | ||
| Last updated 11.16am 17/05/2024 ? | |||||
| IMU (ASX) Chart |